Besides an intrinsic resistance of these neoplasms, as observed by treatment with the VEGF inhibitor sunitinib, an acquired resistance to antiangiogenic treatment can also appear after an initial effective inhibition of angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.